Pubblicazioni

CA19.9 Serum Level Predicts Lymph-Nodes Status in Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis

2021 - FRONTIERS IN ONCOLOGY

Coppola, Alessandro; La Vaccara, Vincenzo; Fiore, Michele; Farolfi, Tommaso; Ramella, Sara; Angeletti, Silvia; Coppola, Roberto; Caputo, Damiano

STAT3 and mutp53 Engage a Positive Feedback Loop Involving HSP90 and the Mevalonate Pathway

2020 - FRONTIERS IN ONCOLOGY

Romeo, M. A.; Gilardini Montani, M. S.; Benedetti, R.; Santarelli, R.; D'Orazi, G.; Cirone, M.

Expression profiling of circulating tumor cells in pancreatic ductal adenocarcinoma patients: biomarkers predicting overall survival

2019 - FRONTIERS IN ONCOLOGY

Amantini, C.; Morelli, M. B.; Nabissi, M.; Piva, F.; Marinelli, O.; Maggi, F.; Bianchi, F.; Bittoni, A.; Berardi, R.; Giampieri, R.; Santoni, G.

Postoperative outcomes and functional recovery after preoperative combination chemotherapy for pancreatic cancer: a propensity score-matched study

2019 - FRONTIERS IN ONCOLOGY

Pecorelli, N.; Pagnanelli, M.; Cinelli, L.; Di Salvo, F.; Partelli, S.; Crippa, S.; Tamburrino, D.; Castoldi, R.; Belfiori, G.; Reni, M.; Falconi, M.; Balzano, G.